In the article titled “Curcumin Analogue CA15 Exhibits Anticancer Effects on HEp-2 Cells via Targeting NF-B” [1], the cell line HEp-2 used in the study had been reported to be contaminated by HeLa, a cervical cancer cell line. Therefore, the study can only prove that the compound CA15 has antitumor effects, not antihuman laryngeal carcinoma.
Corrigendum | Open Access
Corrigendum to “Curcumin Analogue CA15 Exhibits Anticancer Effects on HEp-2 Cells via Targeting NF-κB”
Received01 Nov 2017
Accepted08 Nov 2017
Published28 Dec 2017
References
J. Chen, L. Zhang, Y. Shu et al., “Curcumin analogue CA15 exhibits anticancer effects on HEp-2 cells via targeting NF-κB,” BioMed Research International, vol. 2017, Article ID 4751260, 10 pages, 2017.
View at: Publisher Site | Google Scholar
Copyright
Copyright © 2017 Jian Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.